Q4 2024 Holdings
Filed 2025-02-14 | 28 holdings | $466.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| CG Oncology Inc(CGON) | COM | 156944100 | $182.7M | 6,371,669 | 39.2% |
| Nuvation Bio Inc.(NUVB) | COM | 67080N101 | $69.0M | 25,954,439 | 14.8% |
| Upstream Bio Inc.(UPB) | COM | 91678A107 | $54.0M | 3,285,293 | 11.6% |
| Newamsterdam Pharma Co NV(NAMS) | COM | N62509109 | $19.8M | 770,000 | 4.2% |
| Illumnia, Inc.(ILMN) | COM | 452327109 | $12.7M | 94,767 | 2.7% |
| Arcus Biosciences, Inc(RCUS) | COM | 03969F109 | $12.0M | 808,789 | 2.6% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $12.0M | 76,772 | 2.6% |
| Revolution Medicines Inc(nsm)(RVMD) | COM | 76155X100 | $9.9M | 226,000 | 2.1% |
| Moonlake Immunotherapeutics | COM | G4444C102 | $9.3M | 171,600 | 2.0% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $8.6M | 167,958 | 1.8% |
| BeyondSpring Inc.(BYSI) | SHS | G10830100 | $8.0M | 4,882,651 | 1.7% |
| Merus NV | COM | N5749R100 | $8.0M | 189,098 | 1.7% |
| Lyell Immunopharma, Inc. | COM | 55083R104 | $7.6M | 11,909,341 | 1.6% |
| Zentalis Pharmaceuticals Inc.(ZNTL) | COM | 98943L107 | $7.1M | 2,338,095 | 1.5% |
| Arcellx Inc(ACLX) | COM | 03940C100 | $6.5M | 84,377 | 1.4% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $5.6M | 694,254 | 1.2% |
| Aclaris Therapeutics, Inc.(ACRS) | COM | 00461U105 | $5.6M | 2,266,667 | 1.2% |
| Legend Biotech Corp(LEGN) | ADR | 52490G102 | $5.0M | 153,558 | 1.1% |
| Cytokinetics Inc(CYTK) | COM | 23282W605 | $4.7M | 100,000 | 1.0% |
| Biontech SE(BNTX) | COM | 09075V102 | $4.6M | 40,000 | 1.0% |
| Aura Biosciences, Inc.(AURA) | COM | 05153U107 | $4.2M | 515,555 | 0.9% |
| Equillium Inc.(EQ) | COM | 29446K106 | $3.3M | 4,447,308 | 0.7% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $2.2M | 400,000 | 0.5% |
| Vera Therapeutics Inc(VERA) | COM | 92337R101 | $2.1M | 49,767 | 0.5% |
| AtriCure Inc.(ATRC) | COM | 04963C209 | $818.9K | 26,797 | 0.2% |
| Pyxis Oncology, Inc (formerly Apexigen)(PYXS) | COM | 747324101 | $509.8K | 326,810 | 0.1% |
| Grail Inc(GRAL) | COM | 384747101 | $172.9K | 9,684 | 0.0% |
| Nuvation Bio Inc.(NUVB/WS) | WARRANTS | 67080N119 | $148.6K | 646,057 | 0.0% |